Notice on Convening the 2nd Extraordinary General Meeting in 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Notice on Convening the 2nd Extraordinary General Meeting in 2026
Filed with SSE · · 5 pages · Chinese
Release
HeiLongJiang ZBD Pharmaceutical Co., Ltd. on 6ix
Earlier from HeiLongJiang ZBD Pharmaceutical
- Announcement on Inability to Timely Repay the Raised Funds Temporarily Used to Supplement Working Capital
- Announcement on Progress in Providing Guarantee for Wholly-owned Subsidiaries
- Announcement on Proposed Inclusion of Some Drugs in the Centralized Volume Procurement of National Chinese Patent Medicine Procurement Alliance
- Announcement on Completion of the Pledge Release on the Remaining Pledged Shares of the Non-publicly Issued Exchangeable Corporate Bonds by the Controlling Shareholder
- Special Report on Deposit, Management and Actual Use of Raised Funds in 2025
Later from HeiLongJiang ZBD Pharmaceutical
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
- Announcement on Abnormal Fluctuations in Stock Trading
- Announcement on Providing Guarantee for Wholly-owned Subsidiary
- Announcement on Extension of Pledge of Partial Shares by the Controlling Shareholder
- Indicative Announcement on Proposed Extension of Pledge of Partial Shares by the Controlling Shareholder
Follow HeiLongJiang ZBD Pharmaceutical into a list and get an email when it puts out news.
Follow HeiLongJiang ZBD Pharmaceutical